These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3141117)

  • 1. Elimination of antibiotic-resistant plasmids by quinolone antibiotics.
    Fu KP; Grace ME; Hsiao CL; Hung PP
    Chemotherapy; 1988; 34(5):415-8. PubMed ID: 3141117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curing of plasmid pE194 with novobiocin and coumermycin A1 in Bacillus subtilis and Staphylococcus aureus.
    Gadó I; Tóth I; Szvoboda G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):136-45. PubMed ID: 2823505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Quinolone interactions with gyrase subunit B inhibitors.
    Lewin CS; Howard BM; Smith JT
    J Med Microbiol; 1991 Dec; 35(6):358-62. PubMed ID: 1661337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of fluoroquinolone antibiotics against Plasmodium falciparum in vitro.
    Divo AA; Sartorelli AC; Patton CL; Bia FJ
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1182-6. PubMed ID: 2847647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on mutational cross-resistance between ciprofloxacin, novobiocin and coumermycin in Escherichia coli and Staphylococcus warneri.
    Howard BM; Pinney RJ; Smith JT
    Microbios; 1993; 75(304):185-95. PubMed ID: 8246811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of plasmids from Enterobacteriaceae by 4-quinolone derivatives.
    Michel-Briand Y; Uccelli V; Laporte JM; Plesiat P
    J Antimicrob Chemother; 1986 Dec; 18(6):667-74. PubMed ID: 3029010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.
    Tanaka M; Sato K; Kimura Y; Hayakawa I; Osada Y; Nishino T
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1489-91. PubMed ID: 1656864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curing of Escherichia coli K12 plasmids by coumermycin.
    Danilevskaya ON; Gragerov AI
    Mol Gen Genet; 1980 Apr; 178(1):233-5. PubMed ID: 6991878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of Escherichia coli type 1 fimbrial expression and adherence to uroepithelial cells following exposure of logarithmic phase cells to quinolones at subinhibitory concentrations.
    Breines DM; Burnham JC
    J Antimicrob Chemother; 1994 Aug; 34(2):205-21. PubMed ID: 7814281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of plasmid conjugation by some recently synthetized 4-quinolone compounds.
    Scazzocchio F; Selan L; Oliva B; Schippa S; Cellini L; Renzini G
    Chemioterapia; 1988 Oct; 7(5):295-7. PubMed ID: 3066516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
    Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
    Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism between novobiocin and coumermycin A1 in Bacillus subtilis.
    Gadó I; Széll V; Büki K; Szvoboda G
    Genet Res; 1984 Dec; 44(3):243-50. PubMed ID: 6099304
    [No Abstract]   [Full Text] [Related]  

  • 14. Alteration of bacterial DNA structure, gene expression, and plasmid encoded antibiotic resistance following exposure to enoxacin.
    Courtright JB; Turowski DA; Sonstein SA
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():1-18. PubMed ID: 2834313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of plasmid vectors for gene cloning in Escherichia coli and Bacillus subtilis.
    Bal J; Cegłowski P; Maciag IE
    Acta Microbiol Pol; 1982; 31(3-4):217-25. PubMed ID: 6189371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrepancy between the antibacterial activities and the inhibitory effects on Micrococcus luteus DNA gyrase of 13 quinolones.
    Fu KP; Grace ME; McCloud SJ; Gregory FJ; Hung PP
    Chemotherapy; 1986; 32(6):494-8. PubMed ID: 3026740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of quinolones against different species of staphylococci of recent clinical isolation.
    Rabagliati AM; Fiorio P; Cavallo R; Mills V; Penna R
    J Chemother; 1991 Jan; 3 Suppl 1():176-8. PubMed ID: 12041759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of the maintenance and transfer of antibiotic-resistance plasmids by quinolones].
    Uccelli V; Laporte JM; Michel-Briand Y
    C R Seances Soc Biol Fil; 1985; 179(5):696-9. PubMed ID: 2938699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial & antiplasmid activities of Helicteres isora L.
    Shriram V; Jahagirdar S; Latha C; Kumar V; Dhakephalkar P; Rojatkar S; Shitole MG
    Indian J Med Res; 2010 Jul; 132():94-9. PubMed ID: 20693597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of plasmids by enoxacin and ofloxacin at near inhibitory concentrations.
    Weisser J; Wiedemann B
    J Antimicrob Chemother; 1986 Nov; 18(5):575-83. PubMed ID: 3542924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.